X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4983) 4983
Book Review (842) 842
Publication (342) 342
Newsletter (84) 84
Book Chapter (31) 31
Conference Proceeding (16) 16
Dissertation (10) 10
Newspaper Article (6) 6
Web Resource (4) 4
Book / eBook (2) 2
Magazine Article (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3752) 3752
prostacyclin (3498) 3498
humans (2239) 2239
animals (2054) 2054
male (1452) 1452
female (1091) 1091
pharmacology & pharmacy (978) 978
rats (801) 801
cardiac & cardiovascular systems (647) 647
biochemistry & molecular biology (631) 631
pulmonary hypertension (613) 613
nitric oxide (608) 608
peripheral vascular disease (540) 540
hypertension, pulmonary - drug therapy (526) 526
adult (512) 512
endothelium (505) 505
hypertension (494) 494
middle aged (475) 475
nitric-oxide (467) 467
cells, cultured (464) 464
physiology (463) 463
prostaglandins (452) 452
abridged index medicus (417) 417
expression (414) 414
in vitro techniques (401) 401
respiratory system (401) 401
mice (389) 389
cell biology (384) 384
dose-response relationship, drug (364) 364
epoprostenol - pharmacology (343) 343
therapy (337) 337
epoprostenol - analogs & derivatives (335) 335
pulmonary arterial hypertension (334) 334
hypertension, pulmonary - physiopathology (332) 332
receptor (329) 329
cells (325) 325
endothelium, vascular - metabolism (322) 322
epoprostenol - metabolism (311) 311
hematology (306) 306
research (305) 305
endothelium, vascular - drug effects (290) 290
inhibition (290) 290
thromboxane (290) 290
endothelial-cells (285) 285
activation (284) 284
physiological aspects (274) 274
iloprost (273) 273
receptors (258) 258
aged (253) 253
rats, sprague-dawley (252) 252
prostacyclin analog (250) 250
atherosclerosis (247) 247
treatment outcome (247) 247
release (245) 245
prostacyclin receptor (243) 243
survival (243) 243
pregnancy (242) 242
nitric-oxide synthase (239) 239
endothelin (237) 237
double-blind (234) 234
antihypertensive agents - therapeutic use (233) 233
endocrinology & metabolism (232) 232
prostacyclin production (231) 231
epoprostenol - biosynthesis (224) 224
platelets (220) 220
inflammation (217) 217
epoprostenol - therapeutic use (215) 215
vasodilation - drug effects (213) 213
analysis (212) 212
endothelium, vascular - physiology (209) 209
disease (206) 206
bosentan (204) 204
blood pressure - drug effects (202) 202
drug therapy (202) 202
time factors (202) 202
endothelin receptor antagonists (201) 201
indomethacin - pharmacology (201) 201
signal transduction (200) 200
epoprostenol (198) 198
arterial-hypertension (193) 193
rats, wistar (191) 191
rabbits (189) 189
medicine, research & experimental (188) 188
nitric oxide - metabolism (187) 187
smooth-muscle (186) 186
cyclooxygenase (180) 180
endothelium, vascular - cytology (180) 180
vasodilator agents - pharmacology (180) 180
muscle, smooth, vascular - drug effects (177) 177
disease models, animal (176) 176
care and treatment (173) 173
platelet aggregation - drug effects (173) 173
aspirin (171) 171
cyclooxygenase inhibitors - pharmacology (171) 171
relaxing factor (171) 171
vasoconstriction - drug effects (171) 171
prostaglandin (169) 169
prostanoid receptors (169) 169
continuous intravenous epoprostenol (168) 168
rat (168) 168
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5015) 5015
German (37) 37
French (26) 26
Spanish (17) 17
Japanese (15) 15
Russian (9) 9
Chinese (2) 2
Hungarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
2000, ISBN 0306463083, ix, 310
Contributors. Acknowledgements. Preface. 1. An introduction to prostacyclin and its receptors. 2. The development of prostacyclin analogues. 3. Nonprostanoid... 
Receptors | Prostacyclin | Prostanoids | Biochemistry, general | Neurology | Toxicology | Neurosciences | Biochemistry | Pharmacology/Toxicology
Book
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 10/2008, Volume 1, Issue 5, pp. 349 - 356
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 6, pp. 1383 - 1390
Journal Article
Prostaglandins and Other Lipid Mediators, ISSN 1098-8823, 01/2016, Volume 122, pp. 18 - 27
Prostacyclin (PGI ) is a key mediator involved in cardiovascular homeostasis, acting predominantly on two receptor types; cell surface IP receptor and... 
pulmonary artery hypertension | PGI2 | prostacyclin | thyroid hormone α receptor | NSAID | triiodothyronine | peroxisome proliferator activated receptor | MLS000389544 | non-steroidal anti-inflammatory drug | thyroid hormone β receptor | TRα | Mesenteric artery | PPAR | MLS | TRβ | PAH | Thyroid hormone | PPARβ/δ | Beraprost | Prostacyclin | Triiodothyronine | CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | RATS | IDENTIFICATION | VASCULAR SMOOTH-MUSCLE | CELL BIOLOGY | PROSTANOID RECEPTORS | VESSELS | MICE | NONGENOMIC ACTIONS | AGONIST | Thiazoles - metabolism | Epoprostenol - metabolism | Mesenteric Arteries - physiology | Myography - methods | Rats, Wistar | Thyroid Hormone Receptors beta - chemistry | Humans | Thyroid Hormone Receptors beta - antagonists & inhibitors | Male | Mesenteric Arteries - drug effects | Receptors, Thyroid Hormone - antagonists & inhibitors | Dose-Response Relationship, Drug | Thyroid Hormone Receptors alpha - chemistry | Triiodothyronine - metabolism | Computer Simulation | Protein Domains | Epoprostenol - pharmacology | Triiodothyronine - pharmacology | Thyroid Hormone Receptors beta - metabolism | Models, Molecular | Thyroid Hormone Receptors alpha - antagonists & inhibitors | Receptors, Cytoplasmic and Nuclear - agonists | Binding, Competitive - drug effects | Receptors, Thyroid Hormone - metabolism | Epoprostenol - analogs & derivatives | Animals | Receptors, Thyroid Hormone - chemistry | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Epoprostenol - chemistry | Ligands | Thiazoles - chemistry | Thyroid Hormone Receptors alpha - metabolism | Thiazoles - pharmacology | Vasodilation - drug effects | Receptors, Cytoplasmic and Nuclear - metabolism | Antiandrogens | Models | Thyroid hormones | Analysis | Index Medicus
Journal Article
International Journal of Biochemistry and Cell Biology, ISSN 1357-2725, 2008, Volume 40, Issue 11, pp. 2627 - 2637
Journal Article
by Lu, AK and Zuo, CJ and He, YH and Chen, GL and Piao, LJ and Zhang, J and Xiao, B and Shen, YJ and Tang, J and Kong, DP and Alberti, S and Chen, D and Zuo, SK and Zhang, QQ and Yan, S and Fei, XC and Yuan, F and Zhou, B and Duan, SZ and Yu, Y and Lazarus, M and Su, YC and Breyer, RM and Funk, CD
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 03/2015, Volume 125, Issue 3, pp. 1228 - 1242
Pulmonary arterial hypertension (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmonary disease (COPD).... 
MEDICINE, RESEARCH & EXPERIMENTAL | GROWTH-FACTOR-BETA | PROSTANOID RECEPTORS | BONE MORPHOGENETIC PROTEIN | MATRIX-METALLOPROTEINASE | ARTERIAL-HYPERTENSION | RHO-KINASE INHIBITOR | SMOOTH-MUSCLE-CELLS | EXTRACELLULAR-MATRIX | PROSTAGLANDIN RECEPTORS | PROSTACYCLIN ANALOGS
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 07/2016, Volume 134, Issue 4, pp. 328 - 338
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 01/2013, Volume 365, Issue 1, pp. 11 - 16
► We study whether estradiol reverts oxLDL effects on DDAH/ADMA/NO pathway in HUAEC. ► oxLDL increased ADMA and decreased of DDAH activity. ► oxLDL reduced... 
Asymmetric dimethylarginine | Nitric oxide synthase | Estrogen | PHOSPHORYLATION | HORMONE REPLACEMENT THERAPY | CELL BIOLOGY | SYNTHASE | METABOLISM | DISEASE | ENDOCRINOLOGY & METABOLISM | DYSFUNCTION | POSTMENOPAUSAL WOMEN | PROSTACYCLIN PRODUCTION | Endothelium, Vascular - cytology | Receptors, Estrogen - metabolism | Receptors, G-Protein-Coupled - metabolism | Humans | Endothelium, Vascular - drug effects | Estrogen Antagonists - pharmacology | Isoenzymes - chemistry | Receptors, G-Protein-Coupled - agonists | Estradiol - agonists | Arginine - analogs & derivatives | Nitric Oxide Synthase Type III - chemistry | Estrogen Receptor beta - metabolism | Estrogen Receptor alpha - agonists | Estrogen Receptor beta - agonists | Arginine - antagonists & inhibitors | Isoenzymes - metabolism | Estrogen Receptor alpha - metabolism | Nitric Oxide Synthase Type III - metabolism | Protein Stability | Estrogen Receptor beta - antagonists & inhibitors | Repressor Proteins - metabolism | Amidohydrolases - metabolism | Estradiol - metabolism | Receptors, Estrogen - agonists | Lipoproteins, LDL - adverse effects | Nitric Oxide - antagonists & inhibitors | Cells, Cultured | Receptors, Estrogen - antagonists & inhibitors | Amidohydrolases - antagonists & inhibitors | Estrogen Receptor alpha - antagonists & inhibitors | Amidohydrolases - chemistry | Blotting, Western | Nitric Oxide - agonists | Nitric Oxide Synthase Type III - antagonists & inhibitors | Protein-Arginine N-Methyltransferases - metabolism | Estradiol - chemistry | Lipoproteins, LDL - antagonists & inhibitors | Endothelium, Vascular - metabolism | Umbilical Arteries - cytology | Receptors, G-Protein-Coupled - antagonists & inhibitors | Arginine - adverse effects | Estrogens, Non-Steroidal - pharmacology | Nitric Oxide - metabolism | Arginine - metabolism | Isoenzymes - antagonists & inhibitors | Physiological aspects | Phenols | Estradiol | Nitric oxide | Endothelium | Index Medicus | Human | Proteins | Receptors | Inhibitors | Pathways | Estrogens | Exposure | Endothelial cells
Journal Article